Davion Healthcare Plc (DAVI)
NASDAQ: DAVI · Real-Time Price · USD
1.390
-0.190 (-12.03%)
At close: Nov 11, 2026, 4:00 PM EST
1.330
-0.060 (-4.32%)
Pre-market: Nov 12, 2026, 4:11 AM EST

Davion Healthcare Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Selling, General & Admin
0.821.312.29
Research & Development
-0.013.02
Operating Expenses
0.821.325.31
Operating Income
-0.82-1.32-5.31
Pretax Income
-0.82-1.32-5.31
Net Income
-0.82-1.32-5.31
Net Income to Common
-0.82-1.32-5.31
Net Income Growth
---
Shares Outstanding (Basic)
252315
Shares Outstanding (Diluted)
252315
Shares Change
9.12%50.15%-
EPS (Basic)
-0.03-0.06-0.35
EPS (Diluted)
-0.03-0.06-0.35
EPS Growth
---

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
EBIT
-0.82-1.32-5.31
SEC Filings: 10-K · 10-Q